Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sinali O. Seneviratne"'
Autor:
Sinali O. Seneviratne, Mark Marriott, Sudarshini Ramanathan, Wei Yeh, Fabienne Brilot-Turville, Helmut Butzkueven, Mastura Monif
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Myelin Oligodendrocyte Glycoprotein antibody-associated disease (MOGAD) is most classically associated in both children and adults with phenotypes including bilateral and recurrent optic neuritis (ON) and transverse myelitis (TM),
Externí odkaz:
https://doaj.org/article/bbc4e69b42464ab3bbdae16e92c1c5cc
Publikováno v:
Case Reports in Immunology, Vol 2020 (2020)
Anti-GAD antibody syndrome is a result of the production of antibodies against glutamic acid decarboxylase (GAD), the main enzyme responsible for the production of gamma-aminobutyric acid (GABA). Several neurological manifestations including cerebell
Externí odkaz:
https://doaj.org/article/3dd24bbfe5234c5da0273e41a6e62d10
Autor:
Sinali O. Seneviratne, Kate Drummond, Liyen Katrina Kan, Mastura Monif, David A. Williams, Terence J. O'Brien
Publikováno v:
Purinergic Signal
Gliomas, the most common primary brain cancer, are highly infiltrative and extremely difficult to treat. Despite advancements, current treatment is limited, with patients surviving for a median of 14-15 months post-diagnosis. Previous research has de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17077c4dcc13f37ce30b7970898d31cc
https://pubmed.ncbi.nlm.nih.gov/32870442
https://pubmed.ncbi.nlm.nih.gov/32870442
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 90:A21.2-A21
IntroductionMyelin oligodendrocyte glycoprotein (MOG) antibody mediated disease is an autoimmune demyelinating disorder which can resemble multiple sclerosis (MS).1 2 Thus, this condition can be misdiagnosed and treated as MS.3 We present the clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9b0224937a0489cb6c8ccf0565904e2
https://doi.org/10.1136/jnnp-2019-anzan.57
https://doi.org/10.1136/jnnp-2019-anzan.57